This company is no longer active
NMDB.F Stock Overview
NeonMind Biosciences Inc. engages in the drug development of psychedelic compounds in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
My Notes
Capture your thoughts, links and company narrative
NeonMind Biosciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.23 |
| 52 Week High | CA$6.73 |
| 52 Week Low | CA$0.12 |
| Beta | -1.17 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -95.84% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| NMDB.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -1.4% | 1.2% |
| 1Y | -95.8% | -1.8% | 23.7% |
Return vs Industry: NMDB.F underperformed the US Pharmaceuticals industry which returned -4.4% over the past year.
Return vs Market: NMDB.F underperformed the US Market which returned 15.2% over the past year.
Price Volatility
| NMDB.F volatility | |
|---|---|
| NMDB.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in US Market | 18.0% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: NMDB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NMDB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | n/a | Rob Tessarolo | www.neonmindbiosciences.com |
NeonMind Biosciences Inc. operates as an integrated psychedelic drug development and wellness company in Canada. The company provides psychedelic drugs to address public health needs, including obesity, weight management, and mental health. It operates in two divisions, Pharmaceutical and Medical Services.
NeonMind Biosciences Inc. Fundamentals Summary
| NMDB.F fundamental statistics | |
|---|---|
| Market cap | US$245.73k |
| Earnings (TTM) | -US$1.79m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.1x
P/E RatioIs NMDB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NMDB.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | CA$2.45m |
| Earnings | -CA$2.45m |
Last Reported Earnings
Aug 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.18 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -61.2% |
How did NMDB.F perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2023/03/22 21:22 |
| End of Day Share Price | 2022/12/23 00:00 |
| Earnings | 2022/08/31 |
| Annual Earnings | 2021/11/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
NeonMind Biosciences Inc. is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.